These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30897595)

  • 1. Activated mTOR signaling pathway in myofibers with inherited metabolic defect might be an evidence for mTOR inhibition therapies.
    Lyu JW; Xu XB; Ji KQ; Zhang N; Sun Y; Zhao DD; Zhao YY; Yan CZ
    Chin Med J (Engl); 2019 Apr; 132(7):805-810. PubMed ID: 30897595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR Hyperactivation in down syndrome hippocampus appears early during development.
    Iyer AM; van Scheppingen J; Milenkovic I; Anink JJ; Adle-Biassette H; Kovacs GG; Aronica E
    J Neuropathol Exp Neurol; 2014 Jul; 73(7):671-83. PubMed ID: 24918639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR/p70S6K signal transduction pathway contributes to osteosarcoma progression and patients' prognosis.
    Zhou Q; Deng Z; Zhu Y; Long H; Zhang S; Zhao J
    Med Oncol; 2010 Dec; 27(4):1239-45. PubMed ID: 19936974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mTOR Signal Pathway Is Overactivated in Human Lymphatic Malformations.
    Wang Q; Wang J; Wang M; Xu Y; Xu MN; Yuan SM
    Lymphat Res Biol; 2019 Dec; 17(6):624-629. PubMed ID: 31381473
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
    Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M
    Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated mTOR/P70S6K signaling pathway is involved in insulinoma tumorigenesis.
    Zhan HX; Cong L; Zhao YP; Zhang TP; Chen G; Zhou L; Guo JC
    J Surg Oncol; 2012 Dec; 106(8):972-80. PubMed ID: 22711648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on activation of AKT/mTOR pathway in anaplastic large cell lymphoma].
    Li JF; Li GD; Gu L; Liu WP; Li FY; Liao DY; Ma ZG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):649-53. PubMed ID: 19176054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors.
    Yamada Y; Kohashi K; Fushimi F; Takahashi Y; Setsu N; Endo M; Yamamoto H; Tokunaga S; Iwamoto Y; Oda Y
    Cancer; 2014 Mar; 120(6):864-76. PubMed ID: 24353015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Akt/mammalian target of rapamycin pathway in myxofibrosarcomas.
    Takahashi Y; Kohashi K; Yamada Y; Endo M; Setsu N; Ishii T; Yamamoto H; Iwamoto Y; Oda Y
    Hum Pathol; 2014 May; 45(5):984-93. PubMed ID: 24746202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of PI3K/Akt/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn's disease.
    Long SH; He Y; Chen MH; Cao K; Chen YJ; Chen BL; Mao R; Zhang SH; Zhu ZH; Zeng ZR; Hu PJ
    J Dig Dis; 2013 Dec; 14(12):662-9. PubMed ID: 23962154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides.
    Levidou G; Siakantaris M; Papadaki T; Papadavid E; Vassilakopoulos TP; Angelopoulou MK; Marinos L; Nikolaou V; Economidi A; Antoniou C; Patsouris E; Korkolopoulou P
    J Am Acad Dermatol; 2013 Sep; 69(3):375-84. PubMed ID: 23685026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.
    Patil VV; Guzman M; Carter AN; Rathore G; Yoshor D; Curry D; Wilfong A; Agadi S; Swann JW; Adesina AM; Bhattacharjee MB; Anderson AE
    Neuropathology; 2016 Apr; 36(2):146-56. PubMed ID: 26381727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats.
    Hu LY; Sun ZG; Wen YM; Cheng GZ; Wang SL; Zhao HB; Zhang XR
    Neuroscience; 2010 Sep; 169(3):1046-62. PubMed ID: 20678995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Akt/mTOR/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option.
    Tian J; Wang Y; Guo H; Li R
    Exp Mol Pathol; 2015 Dec; 99(3):435-40. PubMed ID: 26297427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silent Information Regulator 1 Negatively Regulates Atherosclerotic Angiogenesis via Mammalian Target of Rapamycin Complex 1 Signaling Pathway.
    Chen R; Huang Z; Wang J; Chen X; Fu Y; Wang W
    Am J Med Sci; 2018 Aug; 356(2):168-176. PubMed ID: 30219159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids retard skeletal muscle development and myoblast protein synthesis through a mechanistic target of rapamycin (mTOR)-signaling pathway in broilers (Gallus gallus domesticus).
    Wang X; Jia Q; Xiao J; Jiao H; Lin H
    Stress; 2015; 18(6):686-98. PubMed ID: 26371871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma.
    Tasioudi KE; Sakellariou S; Levidou G; Theodorou D; Michalopoulos NV; Patsouris E; Korkolopoulou P; Saetta AA
    APMIS; 2015 Aug; 123(8):639-47. PubMed ID: 25912437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy Between Low Levels of mTOR Activity and High Levels of P-S6 in Primary Central Nervous System Lymphoma May Be Explained by PAS Domain-Containing Serine/Threonine-Protein Kinase-Mediated Phosphorylation.
    Marosvári D; Nagy N; Kriston C; Deák B; Hajdu M; Bödör C; Csala I; Bagó AG; Szállási Z; Sebestyén A; Reiniger L
    J Neuropathol Exp Neurol; 2018 Apr; 77(4):268-273. PubMed ID: 29361117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.